<DOC>
	<DOCNO>NCT00916604</DOCNO>
	<brief_summary>The purpose study assess safety tolerability AZD1656 multiple repeat oral dos Japanese patient type 2 diabetes .</brief_summary>
	<brief_title>To Study Safety , Tolerability , Pharmacokinetics Pharmacodynamics AZD1656 Japanese Type 2 Diabetes Mellitus ( T2DM ) Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Male female nonchildbearing potential Japanese T2DM patient , 3075 year . A body mass index ( BMI ) 19 27 kg/m2 . Diagnosed Diabetes Mellitus patient treat diet exercise two oral antidiabetic drug . Stable glycemic control indicate change treatment within 3 month prior enrollment . Renal dysfunction GFR &lt; 60 mL/min . Systolic pressure ( SBP ) &gt; 160 mmHg diastolic pressure ( DBP ) &gt; 95 mmHg Clinically significant illness clinically relevant trauma , judge investigator , within two week first administration IP . History ischemic heart disease , stroke , transient ischemic attack symptomatic peripheral vascular disease .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>AZD1656</keyword>
	<keyword>Safety</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Pharmacodynamic</keyword>
	<keyword>Multiple ascending dos</keyword>
	<keyword>Japanese</keyword>
	<keyword>T2DM</keyword>
</DOC>